Table 1.
Characteristics of patients with SJIA, FMF, systemic infections, NOMID, MWS, ALL, AML and healthy controls.
| SJIA | FMF | infections | NOMID | MWS | ALL | AML | Healthy controls | |
|---|---|---|---|---|---|---|---|---|
| number | 60 | 17 | 83 | 18 | 17 | 40 | 5 | 45 |
| Age (range) | 9.1 (1.8-18.1) | 11.7 (3.8-18.6) | 8.1 (1.2-33.2) | 11.0 (4.1-32.0) | 34.6 (5.0-73.2) | 6.2 (0.9-14.9) | 11.0 (0.7-16.9) | 16 (1.2-34.3) |
| sex m/f | 32/28 | 11/6 | 43/42 | 10/8 | 8/8 | 18/21 | 3/2 | 26/24 |
| leukocytes/μl (±95%CI) | 16,120 (2,220) | n.d. | 13,300 (1,200) | 17,200 (3,600) | n.d. | 38,290 (36,400) | 33,120 (71,800) | 6,700 (1,100) |
| ESR [mm/h] (±95%CI) | 76 (23) | 38 (21) | 40 (18) | 60 (16) | 24 (9) | 75 (33) | n.d. | 11 (8) |
| CRP [mg/l] (±95%CI) | 84 (19) | 40 (29) | 111 (11) | 68 (19) | 18 (9) | 28 (17) | 17 (50) | <5 |
| S100A12 [ng/ml] (±95%CI) | 7,190 (2690) | 6,720 (4960) | 470 (160) | 720 (450) | 150 (60) | 130 (80) | 45 (60) | 50 (10) |
n.d. not determined